Use access key #2 to skip to page content.
$5.22 -0.11 (-2.06%)
9/5/2008 2:30 PM

DURECT Corp (DRRX)

CAPS Rating:
**

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

View All Commentary (DRRX)

Recs

2

Avatar hackwojr (61.07) Submitted: 8/18/06 11:21 PM : Outperform Start Price: $3.77 DRRX Score: 42.71

Durect has several products in phase II trials that will really be excellent for the treament of post operative pain. Striker, a company that would compete with Durect just purchased something like 18,000,000$ worth of shares of durect. They must think that the new delivery system that durect is making is going to do well. Also, check out the other products that they are developing. They are really great products.

Report this Post Replies: 0 | Reply

Featured Broker Partners